pc3 Search Results


pc 3  (ATCC)
99
ATCC pc 3
Pc 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/PC-3/10__1021_slash_acsptsci__5c00079-117-19-25
Average 99 stars, based on 1 article reviews
pc 3 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

92
LGC Standards human pc3
Figure 1: Expression of IL-27R on hPCa cell lines and assessment of IL-27 effects on hPCa cells in vitro and in vivo. Panel A and B. Expression of WSX-1 (Panel A) and gp130 (panel B) was analysed in <t>PC3,</t> DU145, 22Rv1 and LNCaP cells by flow cytometry. Open profile: WSX-1 (panel A) and gp130 (panel B) staining. Dark profile: isotype matched mAb staining. Experiments were performed at least in triplicate. Panel C. Western blot analyses of WSX-1 in nuclear extracts (n.e.) and membrane extracts (m.e.) from 22Rv1 and DU145 cells. Nuclear extracts were used as negative controls. A specific 70 kDalton (Da) band, corresponding to WSX-1 protein, was observed in membrane but not nuclear extracts obtained from DU145 cells. Panel D. IL-27 inhibits PC3 cell proliferation in vitro, as assessed by CFSE staining. PC3 cells were cultured for 48 and 120 hours with medium alone (left panel) or in the presence of 100 ng/ml hrIL-27 (middle panel). Flow cytometry analyses showed that IL-27 inhibited PC3 cell proliferation after 120 hours of treatment (middle and right panel), as indicated by the higher CFSE intensity in hrIL-27 treated PC3 cells compared to untreated cells at this time point (right panel). Panel E. Flow cytometry analyses showed that IL-27 inhibited DU145 (left panel) cell proliferation after 120 hours of treatment, as indicated by the higher CFSE intensity in hrIL-27 treated cells (dark profile) compared to untreated cells at this time point (light profile). IL-27 did not affect 22Rv1 (middle panel) or LNCaP (right panel) cell proliferation at the same time point. Panel F. IL-27 did not induce apoptosis after 120 hours of treatment in PC3, DU145, 22Rv1 or LNCaP cells.
Human Pc3, supplied by LGC Standards, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/Silikatglas%2C+polished%2C+XRF-SUS%2C+%C3%98/pm24681516-105-10-19
Average 92 stars, based on 1 article reviews
human pc3 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
ATCC pc3 luciferase pc3 luc2
Fig. 1. Piezo1 expression is enhanced by wall shear stress (A) The prostate tumor microenvironment was immunohistochemically stained to evaluate Piezo1 expression. Scale bars represent 250 μm and 25 μm, respectively. (B) <t>PC3</t> human prostate cancer cells were plated in the microfluidics channel and applied shear stress at 0.05 dyne cm−2 for 5 h. After wall shear stress (WSS), gene expression of Piezo1 was confirmed by qRT-PCR (n = 3, independent experiments, two-tailed t- test, *** p < 0.001). (C) Immunofluorescence staining analysis was performed to evaluate Piezo1 expression (red). Cell nuclei were stained with DAPI (blue). Scale bars represent 10 μm. (D) Protein expression of Piezo1 was detected using immunoblotting at 0, 1, 5, and 12 h after WSS.
Pc3 Luciferase Pc3 Luc2, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/PC-3-Luc2/pm36084759-45-1-13
Average 92 stars, based on 1 article reviews
pc3 luciferase pc3 luc2 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

95
DSMZ human prostate carcinoma pc3 cells
Fig. 1. Piezo1 expression is enhanced by wall shear stress (A) The prostate tumor microenvironment was immunohistochemically stained to evaluate Piezo1 expression. Scale bars represent 250 μm and 25 μm, respectively. (B) <t>PC3</t> human prostate cancer cells were plated in the microfluidics channel and applied shear stress at 0.05 dyne cm−2 for 5 h. After wall shear stress (WSS), gene expression of Piezo1 was confirmed by qRT-PCR (n = 3, independent experiments, two-tailed t- test, *** p < 0.001). (C) Immunofluorescence staining analysis was performed to evaluate Piezo1 expression (red). Cell nuclei were stained with DAPI (blue). Scale bars represent 10 μm. (D) Protein expression of Piezo1 was detected using immunoblotting at 0, 1, 5, and 12 h after WSS.
Human Prostate Carcinoma Pc3 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/PC-3/pm26029847-169-10-17
Average 95 stars, based on 1 article reviews
human prostate carcinoma pc3 cells - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Proteintech anti atg3
Fig. 1. Piezo1 expression is enhanced by wall shear stress (A) The prostate tumor microenvironment was immunohistochemically stained to evaluate Piezo1 expression. Scale bars represent 250 μm and 25 μm, respectively. (B) <t>PC3</t> human prostate cancer cells were plated in the microfluidics channel and applied shear stress at 0.05 dyne cm−2 for 5 h. After wall shear stress (WSS), gene expression of Piezo1 was confirmed by qRT-PCR (n = 3, independent experiments, two-tailed t- test, *** p < 0.001). (C) Immunofluorescence staining analysis was performed to evaluate Piezo1 expression (red). Cell nuclei were stained with DAPI (blue). Scale bars represent 10 μm. (D) Protein expression of Piezo1 was detected using immunoblotting at 0, 1, 5, and 12 h after WSS.
Anti Atg3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/ATG3+Antibody/pmc09760476-105-73-76
Average 93 stars, based on 1 article reviews
anti atg3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

97
ATCC human prostate adenocarcinoma cell line
Fig. 1. Piezo1 expression is enhanced by wall shear stress (A) The prostate tumor microenvironment was immunohistochemically stained to evaluate Piezo1 expression. Scale bars represent 250 μm and 25 μm, respectively. (B) <t>PC3</t> human prostate cancer cells were plated in the microfluidics channel and applied shear stress at 0.05 dyne cm−2 for 5 h. After wall shear stress (WSS), gene expression of Piezo1 was confirmed by qRT-PCR (n = 3, independent experiments, two-tailed t- test, *** p < 0.001). (C) Immunofluorescence staining analysis was performed to evaluate Piezo1 expression (red). Cell nuclei were stained with DAPI (blue). Scale bars represent 10 μm. (D) Protein expression of Piezo1 was detected using immunoblotting at 0, 1, 5, and 12 h after WSS.
Human Prostate Adenocarcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/PC-3%3B+Prostate+Adenocarcinoma%3B+Human/10__1093_slash_clinchem_slash_44__6__1170-41-2-16
Average 97 stars, based on 1 article reviews
human prostate adenocarcinoma cell line - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

93
ABclonal Biotechnology atg3
Identification of Draper‐interacting proteins. A) Sodium dodecyl sulfate‐polyacrylamide gel electrophoresis gel image of samples following exogenous Draper immunoprecipitation. The black arrow indicates the Draper protein band. B) Western blotting analysis of Draper–His expression post‐immunoprecipitation. C) Detection of interacting proteins in full gels via LC–MS/MS. PSMs: peptide spectrum matches. D) Protein levels of <t>ATG3</t> and Draper after Draper overexpression in BmN cells. E) ATG3 protein level in the MSG at the prepupal stage. F) Co‐IP analysis of Draper in BmN cells. Immunoprecipitation was performed using anti‐His magnetic beads on lysates of BmN cells expressing Draper, followed by immunoblotting with ATG3 antibody. G) Protein levels of ATG8, SQSTM1, ATG3, and Draper following expression of Draper and coexpression of Draper and ATG3 in BmN cells.
Atg3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/ATG3+Rabbit+pAb/pmc12677660-239-31-32
Average 93 stars, based on 1 article reviews
atg3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
CLS Cell Lines Service GmbH bt 549
Characterizing H3K4me2 enriched lncRNAs. ( A ) ChRIP experimental workflow to identify lncRNAs bound to chromatin enriched with H3K4me2 and WDR5 <t>in</t> <t>BT-549</t> cell line. ( B ) Computational approach used for finding chromatin-associated RNAs and enriched patterns of genomic organization with respect to nearest protein coding genes. ( C ) Scatter plot showing the enrichment of H3K4me2 lncRNAs over input. X-axis denotes log transformed expression values of H3K4me2 lncRNAs and Y-axis denotes log-fold changes of lncRNAs in H3K4me2 ChRIP sample over nuclear input sample. ( D ) Histogram shows distribution of H3K4me2 lncRNAs with antisense (X) and sense (S) pattern with respect to their protein coding partner (pPCGs). ‘n’ denotes number of lncRNA-pPCG pairs in each pattern. ( E ) Genomic organization of H3K4me2 lncRNAs (green bars) with respect to nearest protein coding genes (grey bars). XH: where lncRNA shows Head-to-Head arrangement with nearby protein coding gene. XT: lncRNA in Tail-to-Tail arrangement with protein coding gene, XI: lncRNA located inside a protein coding gene, XO: lncRNA located outside and covers the entire protein coding gene. Sense pairs means lncRNAs in the same orientation as protein coding gene. The notion of greater or less than 2 kb means that the partner genes (pPCGs) are located within 2 kb (<2 kb) or away from 2 kb (> 2 kb) but within 50 kb window with respect to H3K4me2 lncRNAs. ( F ) Distribution of different patterns of genomic arrangements as described in (E) for H3K4me2 lncRNAs and non-CAR lncRNAs.
Bt 549, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/PC-3+Cells/pmc06182144-39-0-1
Average 94 stars, based on 1 article reviews
bt 549 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
OriGene human btg2 gene
Characterizing H3K4me2 enriched lncRNAs. ( A ) ChRIP experimental workflow to identify lncRNAs bound to chromatin enriched with H3K4me2 and WDR5 <t>in</t> <t>BT-549</t> cell line. ( B ) Computational approach used for finding chromatin-associated RNAs and enriched patterns of genomic organization with respect to nearest protein coding genes. ( C ) Scatter plot showing the enrichment of H3K4me2 lncRNAs over input. X-axis denotes log transformed expression values of H3K4me2 lncRNAs and Y-axis denotes log-fold changes of lncRNAs in H3K4me2 ChRIP sample over nuclear input sample. ( D ) Histogram shows distribution of H3K4me2 lncRNAs with antisense (X) and sense (S) pattern with respect to their protein coding partner (pPCGs). ‘n’ denotes number of lncRNA-pPCG pairs in each pattern. ( E ) Genomic organization of H3K4me2 lncRNAs (green bars) with respect to nearest protein coding genes (grey bars). XH: where lncRNA shows Head-to-Head arrangement with nearby protein coding gene. XT: lncRNA in Tail-to-Tail arrangement with protein coding gene, XI: lncRNA located inside a protein coding gene, XO: lncRNA located outside and covers the entire protein coding gene. Sense pairs means lncRNAs in the same orientation as protein coding gene. The notion of greater or less than 2 kb means that the partner genes (pPCGs) are located within 2 kb (<2 kb) or away from 2 kb (> 2 kb) but within 50 kb window with respect to H3K4me2 lncRNAs. ( F ) Distribution of different patterns of genomic arrangements as described in (E) for H3K4me2 lncRNAs and non-CAR lncRNAs.
Human Btg2 Gene, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/BTG2+(NM_006763)+Human+Untagged+Clone/pmc05067507-39-11-20
Average 90 stars, based on 1 article reviews
human btg2 gene - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
MedChemExpress pc 3 pc 3 dr cells
Differential expression and prognostic analysis of APOBEC3B. A. The mRNA expression of APOBEC3B in different tumour tissues and adjacent normal tissues based on the TCGA database. B. APOBEC3B expression in 52 pairs of PCa tissues and adjacent normal tissues in the TCGA database. C. APOBEC3B expression with Gleason Score in PCa patients based on TCGA database. D. PCa patients’ DFS for individuals in the TCGA database was assessed in terms of quartile via the Kaplan-Meier method (Log-rank test) using GEPIA2. E. APOBEC3B expression in docetaxel-resistant PCa cells (DU145/DR and <t>PC-3/DR)</t> and corresponding parental sensitive cells (DU145 and PC-3) measured by qRT-PCR and Western blot. U6 was used as a normalization reference at the mRNA level, and GAPDH was used as a loading control at the protein level. *, P <0.05; **, P <0.01; ***, P <0.001; ****, P <0.0001.
Pc 3 Pc 3 Dr Cells, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/Phytochelatin+3/pmc10302536-65-14-29
Average 94 stars, based on 1 article reviews
pc 3 pc 3 dr cells - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
ATCC distribution
Differential expression and prognostic analysis of APOBEC3B. A. The mRNA expression of APOBEC3B in different tumour tissues and adjacent normal tissues based on the TCGA database. B. APOBEC3B expression in 52 pairs of PCa tissues and adjacent normal tissues in the TCGA database. C. APOBEC3B expression with Gleason Score in PCa patients based on TCGA database. D. PCa patients’ DFS for individuals in the TCGA database was assessed in terms of quartile via the Kaplan-Meier method (Log-rank test) using GEPIA2. E. APOBEC3B expression in docetaxel-resistant PCa cells (DU145/DR and <t>PC-3/DR)</t> and corresponding parental sensitive cells (DU145 and PC-3) measured by qRT-PCR and Western blot. U6 was used as a normalization reference at the mRNA level, and GAPDH was used as a loading control at the protein level. *, P <0.05; **, P <0.01; ***, P <0.001; ****, P <0.0001.
Distribution, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/Exosomes%3B+PC-3+Adenocarcinoma%3B+Human/pmc01850536-42-14-15
Average 90 stars, based on 1 article reviews
distribution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology pc3 cell nuclear extracts
Expression of ERG, ETS-1, ETS-2 and ETV-4 in <t>PC3</t> cell nuclear extracts and PCa tissues. Western blot analysis showed that ERG, ETS-1, ETS-2 and ETV-4 were expressed in (A) PC3 cell nuclear extracts, as well as in protein lysates prepared from (B) the PCa tissue samples of five patients.
Pc3 Cell Nuclear Extracts, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc3/PC-3+nuclear+extract/pmc03572757-35-12-16
Average 93 stars, based on 1 article reviews
pc3 cell nuclear extracts - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Figure 1: Expression of IL-27R on hPCa cell lines and assessment of IL-27 effects on hPCa cells in vitro and in vivo. Panel A and B. Expression of WSX-1 (Panel A) and gp130 (panel B) was analysed in PC3, DU145, 22Rv1 and LNCaP cells by flow cytometry. Open profile: WSX-1 (panel A) and gp130 (panel B) staining. Dark profile: isotype matched mAb staining. Experiments were performed at least in triplicate. Panel C. Western blot analyses of WSX-1 in nuclear extracts (n.e.) and membrane extracts (m.e.) from 22Rv1 and DU145 cells. Nuclear extracts were used as negative controls. A specific 70 kDalton (Da) band, corresponding to WSX-1 protein, was observed in membrane but not nuclear extracts obtained from DU145 cells. Panel D. IL-27 inhibits PC3 cell proliferation in vitro, as assessed by CFSE staining. PC3 cells were cultured for 48 and 120 hours with medium alone (left panel) or in the presence of 100 ng/ml hrIL-27 (middle panel). Flow cytometry analyses showed that IL-27 inhibited PC3 cell proliferation after 120 hours of treatment (middle and right panel), as indicated by the higher CFSE intensity in hrIL-27 treated PC3 cells compared to untreated cells at this time point (right panel). Panel E. Flow cytometry analyses showed that IL-27 inhibited DU145 (left panel) cell proliferation after 120 hours of treatment, as indicated by the higher CFSE intensity in hrIL-27 treated cells (dark profile) compared to untreated cells at this time point (light profile). IL-27 did not affect 22Rv1 (middle panel) or LNCaP (right panel) cell proliferation at the same time point. Panel F. IL-27 did not induce apoptosis after 120 hours of treatment in PC3, DU145, 22Rv1 or LNCaP cells.

Journal: Oncotarget

Article Title: The antitumor potential of Interleukin-27 in prostate cancer.

doi: 10.18632/oncotarget.1425

Figure Lengend Snippet: Figure 1: Expression of IL-27R on hPCa cell lines and assessment of IL-27 effects on hPCa cells in vitro and in vivo. Panel A and B. Expression of WSX-1 (Panel A) and gp130 (panel B) was analysed in PC3, DU145, 22Rv1 and LNCaP cells by flow cytometry. Open profile: WSX-1 (panel A) and gp130 (panel B) staining. Dark profile: isotype matched mAb staining. Experiments were performed at least in triplicate. Panel C. Western blot analyses of WSX-1 in nuclear extracts (n.e.) and membrane extracts (m.e.) from 22Rv1 and DU145 cells. Nuclear extracts were used as negative controls. A specific 70 kDalton (Da) band, corresponding to WSX-1 protein, was observed in membrane but not nuclear extracts obtained from DU145 cells. Panel D. IL-27 inhibits PC3 cell proliferation in vitro, as assessed by CFSE staining. PC3 cells were cultured for 48 and 120 hours with medium alone (left panel) or in the presence of 100 ng/ml hrIL-27 (middle panel). Flow cytometry analyses showed that IL-27 inhibited PC3 cell proliferation after 120 hours of treatment (middle and right panel), as indicated by the higher CFSE intensity in hrIL-27 treated PC3 cells compared to untreated cells at this time point (right panel). Panel E. Flow cytometry analyses showed that IL-27 inhibited DU145 (left panel) cell proliferation after 120 hours of treatment, as indicated by the higher CFSE intensity in hrIL-27 treated cells (dark profile) compared to untreated cells at this time point (light profile). IL-27 did not affect 22Rv1 (middle panel) or LNCaP (right panel) cell proliferation at the same time point. Panel F. IL-27 did not induce apoptosis after 120 hours of treatment in PC3, DU145, 22Rv1 or LNCaP cells.

Article Snippet: Cell culture, antibodies, reagents, flow cytometry and western blot The human PC3, DU145, 22Rv1 and LNCaP PCa cell lines (LGC Standards, Teddington, UK) were cultured in RPMI 1640 with 10% FCS (Seromed-BiochromKG, Berlin, D). hrIL-27 (R&D System, Minneapolis, MN, USA) was used at 100 ng/ml following titration experiments.

Techniques: Expressing, In Vitro, In Vivo, Flow Cytometry, Staining, Western Blot, Membrane, Cell Culture

Figure 2: Inhibition of human PC3 and DU145 cell growth in vivo by IL-27 treatment. Panel A. Tumor growth curve from day 14 to day 51 after PC3 s.c. cell injection into athymic nude mice was obtained by measuring tumor volume in situ using a caliper. Dark line represents growth curve (volume) of tumors formed in mice injected with PC3 cells and treated with PBS (controls). Grey light line represents growth curve of tumors formed in mice injected with PC3 cells and treated with hrIL-27. Asterisks mean significant differences (see results section). Panel B. Volume of tumor masses developed in mice injected with the DU145 cell line and subsequently treated with PBS (controls) or hrIL-27. Panel C and D. Morphological and immunohistochemical features of PC3 (C) and DU145 (D) tumor masses grown in hrIL-27 or PBS treated mice. Expression of WSX-1 was preserved in vivo by tumor developed after s.c. injection of PC3 or DU145 cells in both control (a) and hrIL-27 treated (b) mice. The proliferative activity of PC3 tumors grown in PBS treated animals (c) was considerably reduced in tumors from hrIL-27 treated animals (d). The histologic feature of poorly differentiated tumor with a solid growth pattern (e) and endowed with a well-developed vascularization (g) observed in PBS treated animals, was heavily compromised in tumors from hrIL-27 treated animals which showed multiple foci of ischemic necrosis (f) along with a deficient vascular supply (h). PC3 tumors revealed a strong expression of the anti-angiogenic chemokine IP-10/CXCL10 (j), which, on the contrary, was barely detected in tumors from PBS treated animals (i). (a-j: x400). Panel E. Expression profile of genes involved in angiogenic pathways in PC3 (white bars) and DU145 (black bars) cells treated with hrIL-27. Pooled results ± SD from two experiments performed in duplicate are shown. Histogram represents fold differences of individual mRNA between cells cultured in presence or absence of hrIL-27.

Journal: Oncotarget

Article Title: The antitumor potential of Interleukin-27 in prostate cancer.

doi: 10.18632/oncotarget.1425

Figure Lengend Snippet: Figure 2: Inhibition of human PC3 and DU145 cell growth in vivo by IL-27 treatment. Panel A. Tumor growth curve from day 14 to day 51 after PC3 s.c. cell injection into athymic nude mice was obtained by measuring tumor volume in situ using a caliper. Dark line represents growth curve (volume) of tumors formed in mice injected with PC3 cells and treated with PBS (controls). Grey light line represents growth curve of tumors formed in mice injected with PC3 cells and treated with hrIL-27. Asterisks mean significant differences (see results section). Panel B. Volume of tumor masses developed in mice injected with the DU145 cell line and subsequently treated with PBS (controls) or hrIL-27. Panel C and D. Morphological and immunohistochemical features of PC3 (C) and DU145 (D) tumor masses grown in hrIL-27 or PBS treated mice. Expression of WSX-1 was preserved in vivo by tumor developed after s.c. injection of PC3 or DU145 cells in both control (a) and hrIL-27 treated (b) mice. The proliferative activity of PC3 tumors grown in PBS treated animals (c) was considerably reduced in tumors from hrIL-27 treated animals (d). The histologic feature of poorly differentiated tumor with a solid growth pattern (e) and endowed with a well-developed vascularization (g) observed in PBS treated animals, was heavily compromised in tumors from hrIL-27 treated animals which showed multiple foci of ischemic necrosis (f) along with a deficient vascular supply (h). PC3 tumors revealed a strong expression of the anti-angiogenic chemokine IP-10/CXCL10 (j), which, on the contrary, was barely detected in tumors from PBS treated animals (i). (a-j: x400). Panel E. Expression profile of genes involved in angiogenic pathways in PC3 (white bars) and DU145 (black bars) cells treated with hrIL-27. Pooled results ± SD from two experiments performed in duplicate are shown. Histogram represents fold differences of individual mRNA between cells cultured in presence or absence of hrIL-27.

Article Snippet: Cell culture, antibodies, reagents, flow cytometry and western blot The human PC3, DU145, 22Rv1 and LNCaP PCa cell lines (LGC Standards, Teddington, UK) were cultured in RPMI 1640 with 10% FCS (Seromed-BiochromKG, Berlin, D). hrIL-27 (R&D System, Minneapolis, MN, USA) was used at 100 ng/ml following titration experiments.

Techniques: Inhibition, In Vivo, Injection, In Situ, Immunohistochemical staining, Expressing, Control, Activity Assay, Cell Culture

Fig. 1. Piezo1 expression is enhanced by wall shear stress (A) The prostate tumor microenvironment was immunohistochemically stained to evaluate Piezo1 expression. Scale bars represent 250 μm and 25 μm, respectively. (B) PC3 human prostate cancer cells were plated in the microfluidics channel and applied shear stress at 0.05 dyne cm−2 for 5 h. After wall shear stress (WSS), gene expression of Piezo1 was confirmed by qRT-PCR (n = 3, independent experiments, two-tailed t- test, *** p < 0.001). (C) Immunofluorescence staining analysis was performed to evaluate Piezo1 expression (red). Cell nuclei were stained with DAPI (blue). Scale bars represent 10 μm. (D) Protein expression of Piezo1 was detected using immunoblotting at 0, 1, 5, and 12 h after WSS.

Journal: Life sciences

Article Title: Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axis.

doi: 10.1016/j.lfs.2022.120936

Figure Lengend Snippet: Fig. 1. Piezo1 expression is enhanced by wall shear stress (A) The prostate tumor microenvironment was immunohistochemically stained to evaluate Piezo1 expression. Scale bars represent 250 μm and 25 μm, respectively. (B) PC3 human prostate cancer cells were plated in the microfluidics channel and applied shear stress at 0.05 dyne cm−2 for 5 h. After wall shear stress (WSS), gene expression of Piezo1 was confirmed by qRT-PCR (n = 3, independent experiments, two-tailed t- test, *** p < 0.001). (C) Immunofluorescence staining analysis was performed to evaluate Piezo1 expression (red). Cell nuclei were stained with DAPI (blue). Scale bars represent 10 μm. (D) Protein expression of Piezo1 was detected using immunoblotting at 0, 1, 5, and 12 h after WSS.

Article Snippet: PC3, PC3-Luciferase (PC3-Luc2), and DU145 human prostate cancer cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA).

Techniques: Expressing, Shear, Staining, Gene Expression, Quantitative RT-PCR, Two Tailed Test, Immunofluorescence, Western Blot

Fig. 5. Piezo1 induces YAP activation through tyrosine 357 YAP and Src phosphorylation (A) and (B) Immunoblot analysis was measured after treatment with mock, a Piezo1 agonist (Yoda1, 1 μM), and an Src inhibitor (dasatinib, 100 nM) and exposure to static or WSS for 5 h. (C) and (D) Immunoblot analysis was measured after exposure to WSS for 5 h in PC3 cells transfected with siControl or siPiezo1. (B) and (D) Graphs showing quantification of the expression level of each phosphorylated protein compared with the expression of the non-phosphorylated isoform. (n = 3, Two Way ANOVA with Holm-Sidak multiple comparisons, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).

Journal: Life sciences

Article Title: Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axis.

doi: 10.1016/j.lfs.2022.120936

Figure Lengend Snippet: Fig. 5. Piezo1 induces YAP activation through tyrosine 357 YAP and Src phosphorylation (A) and (B) Immunoblot analysis was measured after treatment with mock, a Piezo1 agonist (Yoda1, 1 μM), and an Src inhibitor (dasatinib, 100 nM) and exposure to static or WSS for 5 h. (C) and (D) Immunoblot analysis was measured after exposure to WSS for 5 h in PC3 cells transfected with siControl or siPiezo1. (B) and (D) Graphs showing quantification of the expression level of each phosphorylated protein compared with the expression of the non-phosphorylated isoform. (n = 3, Two Way ANOVA with Holm-Sidak multiple comparisons, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).

Article Snippet: PC3, PC3-Luciferase (PC3-Luc2), and DU145 human prostate cancer cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA).

Techniques: Activation Assay, Phospho-proteomics, Western Blot, Transfection, Expressing

Fig. 6. In vivo monitoring of orthotopic PC3 pros tate tumor growth and metastasis with or without shPiezo1. (A) Representative whole-body images of bioluminescence measurements for xenografted PC3 tumor growth and metastasis. Luciferase tag ged PC3-Luc/shCon and PC3-Luc/shPiezo1 cells were surgically implanted into the dorsal prostate of male nude mice. Ventral images of anesthetized representative sham, control (PC3-Luc/shCon), and shPiezo1 (PC3-Luc/shPiezo1) were taken weekly for 6 weeks to monitor spreading to other organs. All images were pseudo color set using the same intensity (sham = 4, shCon = 6, shPiezo1 = 6). (B) Histological slides include orthotopic tumors of PC3-luc/shCon and PC3-luc/shPiezo1. Representa tive images were derived from mouse prostate stained with hematoxylin and eosin (H&E). High magnified images of the top panel were presented as below. Scale bars = 25 μm and 100 μm, respectively.

Journal: Life sciences

Article Title: Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axis.

doi: 10.1016/j.lfs.2022.120936

Figure Lengend Snippet: Fig. 6. In vivo monitoring of orthotopic PC3 pros tate tumor growth and metastasis with or without shPiezo1. (A) Representative whole-body images of bioluminescence measurements for xenografted PC3 tumor growth and metastasis. Luciferase tag ged PC3-Luc/shCon and PC3-Luc/shPiezo1 cells were surgically implanted into the dorsal prostate of male nude mice. Ventral images of anesthetized representative sham, control (PC3-Luc/shCon), and shPiezo1 (PC3-Luc/shPiezo1) were taken weekly for 6 weeks to monitor spreading to other organs. All images were pseudo color set using the same intensity (sham = 4, shCon = 6, shPiezo1 = 6). (B) Histological slides include orthotopic tumors of PC3-luc/shCon and PC3-luc/shPiezo1. Representa tive images were derived from mouse prostate stained with hematoxylin and eosin (H&E). High magnified images of the top panel were presented as below. Scale bars = 25 μm and 100 μm, respectively.

Article Snippet: PC3, PC3-Luciferase (PC3-Luc2), and DU145 human prostate cancer cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA).

Techniques: In Vivo, Luciferase, Control, Derivative Assay, Staining

Identification of Draper‐interacting proteins. A) Sodium dodecyl sulfate‐polyacrylamide gel electrophoresis gel image of samples following exogenous Draper immunoprecipitation. The black arrow indicates the Draper protein band. B) Western blotting analysis of Draper–His expression post‐immunoprecipitation. C) Detection of interacting proteins in full gels via LC–MS/MS. PSMs: peptide spectrum matches. D) Protein levels of ATG3 and Draper after Draper overexpression in BmN cells. E) ATG3 protein level in the MSG at the prepupal stage. F) Co‐IP analysis of Draper in BmN cells. Immunoprecipitation was performed using anti‐His magnetic beads on lysates of BmN cells expressing Draper, followed by immunoblotting with ATG3 antibody. G) Protein levels of ATG8, SQSTM1, ATG3, and Draper following expression of Draper and coexpression of Draper and ATG3 in BmN cells.

Journal: Advanced Science

Article Title: Draper‐ATG3 Interaction Positively Regulates Autophagy to Mediate Silk Gland Degradation in Bombyx mori

doi: 10.1002/advs.202504664

Figure Lengend Snippet: Identification of Draper‐interacting proteins. A) Sodium dodecyl sulfate‐polyacrylamide gel electrophoresis gel image of samples following exogenous Draper immunoprecipitation. The black arrow indicates the Draper protein band. B) Western blotting analysis of Draper–His expression post‐immunoprecipitation. C) Detection of interacting proteins in full gels via LC–MS/MS. PSMs: peptide spectrum matches. D) Protein levels of ATG3 and Draper after Draper overexpression in BmN cells. E) ATG3 protein level in the MSG at the prepupal stage. F) Co‐IP analysis of Draper in BmN cells. Immunoprecipitation was performed using anti‐His magnetic beads on lysates of BmN cells expressing Draper, followed by immunoblotting with ATG3 antibody. G) Protein levels of ATG8, SQSTM1, ATG3, and Draper following expression of Draper and coexpression of Draper and ATG3 in BmN cells.

Article Snippet: The standard western blotting procedure was carried out using antibodies targeting Draper (produced in our laboratory; 1:1 000), ATG8 (1:2000), ICE (produced in our laboratory; 1:2000), SQSTM1 (ABclonal Technology, A18679; 1:2000), ATG3 (ABclonal Technology, A5809; 1:2000), anti‐His (Proteintech Group, Inc, 66005‐1‐Ig; 1:2000), anti‐Flag (Hangzhou Huaan Biotechnology, M1403‐2; 1:2000) and Tubulin (1: 10 000).

Techniques: Polyacrylamide Gel Electrophoresis, Immunoprecipitation, Western Blot, Expressing, Liquid Chromatography with Mass Spectroscopy, Over Expression, Co-Immunoprecipitation Assay, Magnetic Beads

Schematic representation of Draper in regulating autophagy and subsequent degradation of MSG. ATG3 promotes autophagy by inducing ATG8 lipidation. Draper interacts with ATG3 to positively regulate autophagy and then promote the degradation of MSG.

Journal: Advanced Science

Article Title: Draper‐ATG3 Interaction Positively Regulates Autophagy to Mediate Silk Gland Degradation in Bombyx mori

doi: 10.1002/advs.202504664

Figure Lengend Snippet: Schematic representation of Draper in regulating autophagy and subsequent degradation of MSG. ATG3 promotes autophagy by inducing ATG8 lipidation. Draper interacts with ATG3 to positively regulate autophagy and then promote the degradation of MSG.

Article Snippet: The standard western blotting procedure was carried out using antibodies targeting Draper (produced in our laboratory; 1:1 000), ATG8 (1:2000), ICE (produced in our laboratory; 1:2000), SQSTM1 (ABclonal Technology, A18679; 1:2000), ATG3 (ABclonal Technology, A5809; 1:2000), anti‐His (Proteintech Group, Inc, 66005‐1‐Ig; 1:2000), anti‐Flag (Hangzhou Huaan Biotechnology, M1403‐2; 1:2000) and Tubulin (1: 10 000).

Techniques:

Characterizing H3K4me2 enriched lncRNAs. ( A ) ChRIP experimental workflow to identify lncRNAs bound to chromatin enriched with H3K4me2 and WDR5 in BT-549 cell line. ( B ) Computational approach used for finding chromatin-associated RNAs and enriched patterns of genomic organization with respect to nearest protein coding genes. ( C ) Scatter plot showing the enrichment of H3K4me2 lncRNAs over input. X-axis denotes log transformed expression values of H3K4me2 lncRNAs and Y-axis denotes log-fold changes of lncRNAs in H3K4me2 ChRIP sample over nuclear input sample. ( D ) Histogram shows distribution of H3K4me2 lncRNAs with antisense (X) and sense (S) pattern with respect to their protein coding partner (pPCGs). ‘n’ denotes number of lncRNA-pPCG pairs in each pattern. ( E ) Genomic organization of H3K4me2 lncRNAs (green bars) with respect to nearest protein coding genes (grey bars). XH: where lncRNA shows Head-to-Head arrangement with nearby protein coding gene. XT: lncRNA in Tail-to-Tail arrangement with protein coding gene, XI: lncRNA located inside a protein coding gene, XO: lncRNA located outside and covers the entire protein coding gene. Sense pairs means lncRNAs in the same orientation as protein coding gene. The notion of greater or less than 2 kb means that the partner genes (pPCGs) are located within 2 kb (<2 kb) or away from 2 kb (> 2 kb) but within 50 kb window with respect to H3K4me2 lncRNAs. ( F ) Distribution of different patterns of genomic arrangements as described in (E) for H3K4me2 lncRNAs and non-CAR lncRNAs.

Journal: Nucleic Acids Research

Article Title: H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units

doi: 10.1093/nar/gky635

Figure Lengend Snippet: Characterizing H3K4me2 enriched lncRNAs. ( A ) ChRIP experimental workflow to identify lncRNAs bound to chromatin enriched with H3K4me2 and WDR5 in BT-549 cell line. ( B ) Computational approach used for finding chromatin-associated RNAs and enriched patterns of genomic organization with respect to nearest protein coding genes. ( C ) Scatter plot showing the enrichment of H3K4me2 lncRNAs over input. X-axis denotes log transformed expression values of H3K4me2 lncRNAs and Y-axis denotes log-fold changes of lncRNAs in H3K4me2 ChRIP sample over nuclear input sample. ( D ) Histogram shows distribution of H3K4me2 lncRNAs with antisense (X) and sense (S) pattern with respect to their protein coding partner (pPCGs). ‘n’ denotes number of lncRNA-pPCG pairs in each pattern. ( E ) Genomic organization of H3K4me2 lncRNAs (green bars) with respect to nearest protein coding genes (grey bars). XH: where lncRNA shows Head-to-Head arrangement with nearby protein coding gene. XT: lncRNA in Tail-to-Tail arrangement with protein coding gene, XI: lncRNA located inside a protein coding gene, XO: lncRNA located outside and covers the entire protein coding gene. Sense pairs means lncRNAs in the same orientation as protein coding gene. The notion of greater or less than 2 kb means that the partner genes (pPCGs) are located within 2 kb (<2 kb) or away from 2 kb (> 2 kb) but within 50 kb window with respect to H3K4me2 lncRNAs. ( F ) Distribution of different patterns of genomic arrangements as described in (E) for H3K4me2 lncRNAs and non-CAR lncRNAs.

Article Snippet: BT-549 (CLS-300312; CLS cell line service, Germany), MDA-MB-231 (ACC-732; American Type Culture Collection, USA) and Hela (ATCC CCL-2) cell lines were cultured in DMEM (Invitrogen) supplemented with 10% FBS (Invitrogen) and 1% antibiotic cocktail (Pen-Strep, Invitrogen) at 37°C with 5% CO 2 supply.

Techniques: Transformation Assay, Expressing

H3K4me2 XH lncRNAs regulate the transcriptional activity of their protein coding partners. ( A ) Nuclear expression levels of H3K4me2 XH lncRNAs and non-CAR XH lncRNAs. ( B ) Expression of H3K4me2 XH lncRNA-protein coding pairs (pPCGs) in nuclear input and H3K4me2 ChRIP samples. The P -value denotes the significance of difference between nuclear input and H3K4me2. ( C ) Gene ontology based functional enrichment analysis of protein coding genes that are partners (pPCGs) to H3K4me2 lncRNAs: divergent (XH), other antisense (XT, XI, and XO) and sense lncRNAs. The bar graph shows number of genes in corresponding ontology term and the heatmap represents the significance of individual terms ( P -values obtained using GeneSCF). The highlighted box, by the heatmap, is listed with different transcription factors from the enriched transcription related terms. ( D ) Gene expression analysis of three transcription factors ( FOXD3, GATA6 and HOXC13 ) using RT–qPCR analysis following downregulation of their neighboring H3K4me2 XH lncRNAs ( FOXD3-AS1, GATA6-AS1 and HOXC13-AS ) with siRNA in BT-549 cells. LncRNA expression is in green bars while transcription factors expression is in grey. Data represent the mean ± SD. of two independent biological experiments. * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( E ) RT–qPCR analysis of FOXD3, GATA6 and HOXC13 gene expression after strand-specific downregulation of FOXD3-AS1, GATA6-AS1 and HOXC13-AS respectively, using LNA. Data represent the mean ± SD. of two independent biological experiments. * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( F ) Gene expression analysis of three H3K4me2 XH lncRNAs ( FOXD3-AS1, GATA6-AS1 and HOXC13-AS ) using RT–qPCR analysis following downregulation of their respective transcription factor partners with siRNA or esiRNA in BT-549 cells. LncRNAs expression is depicted as green bars while transcription factors expression is in grey bars. Data represent the mean ± SD. of two independent biological experiments. * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ns denotes non-significant.

Journal: Nucleic Acids Research

Article Title: H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units

doi: 10.1093/nar/gky635

Figure Lengend Snippet: H3K4me2 XH lncRNAs regulate the transcriptional activity of their protein coding partners. ( A ) Nuclear expression levels of H3K4me2 XH lncRNAs and non-CAR XH lncRNAs. ( B ) Expression of H3K4me2 XH lncRNA-protein coding pairs (pPCGs) in nuclear input and H3K4me2 ChRIP samples. The P -value denotes the significance of difference between nuclear input and H3K4me2. ( C ) Gene ontology based functional enrichment analysis of protein coding genes that are partners (pPCGs) to H3K4me2 lncRNAs: divergent (XH), other antisense (XT, XI, and XO) and sense lncRNAs. The bar graph shows number of genes in corresponding ontology term and the heatmap represents the significance of individual terms ( P -values obtained using GeneSCF). The highlighted box, by the heatmap, is listed with different transcription factors from the enriched transcription related terms. ( D ) Gene expression analysis of three transcription factors ( FOXD3, GATA6 and HOXC13 ) using RT–qPCR analysis following downregulation of their neighboring H3K4me2 XH lncRNAs ( FOXD3-AS1, GATA6-AS1 and HOXC13-AS ) with siRNA in BT-549 cells. LncRNA expression is in green bars while transcription factors expression is in grey. Data represent the mean ± SD. of two independent biological experiments. * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( E ) RT–qPCR analysis of FOXD3, GATA6 and HOXC13 gene expression after strand-specific downregulation of FOXD3-AS1, GATA6-AS1 and HOXC13-AS respectively, using LNA. Data represent the mean ± SD. of two independent biological experiments. * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( F ) Gene expression analysis of three H3K4me2 XH lncRNAs ( FOXD3-AS1, GATA6-AS1 and HOXC13-AS ) using RT–qPCR analysis following downregulation of their respective transcription factor partners with siRNA or esiRNA in BT-549 cells. LncRNAs expression is depicted as green bars while transcription factors expression is in grey bars. Data represent the mean ± SD. of two independent biological experiments. * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ns denotes non-significant.

Article Snippet: BT-549 (CLS-300312; CLS cell line service, Germany), MDA-MB-231 (ACC-732; American Type Culture Collection, USA) and Hela (ATCC CCL-2) cell lines were cultured in DMEM (Invitrogen) supplemented with 10% FBS (Invitrogen) and 1% antibiotic cocktail (Pen-Strep, Invitrogen) at 37°C with 5% CO 2 supply.

Techniques: Activity Assay, Expressing, Functional Assay, Gene Expression, Quantitative RT-PCR, esiRNA

XH lncRNAs are overrepresented in active lncCARs. ( A ) Scatter plot showing enrichment of WDR5 lncRNAs over nuclear input. The X-axis denotes log transformed expression and Y-axis denotes log-fold change of WDR5 lncRNAs over nuclear input. Venn diagram, in the Scatter plot, shows 209 lncRNAs that are commonly enriched in both H3K4me2 and WDR5 ChRIP pulldowns. ( B ) Distribution of different patterns of genomic arrangements as described in Figure for WDR5 lncRNAs and non-CAR lncRNAs. ( C ) Distribution of different patterns of genomic arrangements as described in Figure for active lncRNA (ChRIP pulldown using H3K4me2 and WDR5 antibodies) and inactive lncRNA (ChRIP pulldown using EZH2 and H3K27me3 antibodies). ( D ) Nuclear expression levels of WDR5 XH lncRNAs, active XH lncCAR (WDR5 and H3K4me2) and non-CAR XH lncRNAs. ( E ) Enrichment of H3K4me2, H3K4me3, WDR5 ChIP-seq signals over active XH lncCAR (in green, n = 98) and non-CAR XH lncRNA (in black, n = 335) promoters (±2 kb) in BT-549 cells. The signals presented in the plots represent log 2 ratio between ChIP and input sample. TSS denotes the transcription start site of lncRNAs. ( F ) RT-qPCR analysis of WDR5 UV-RIP. The Y-axis shows fold enrichment relative to IgG. The significance of FOXD3-AS1 and HOXC13-AS enrichment in WDR5 RIP is calculated compared to the enrichment of FOXD3 and HOXC13 mRNAs, respectively. *** P ≤ 0.001. ( G ) Left panel: f-RIP of WDR5 WT and WDR5 F266A using FLAG antibody. The Y-axis shows percentage of Input. The significance of decrease in FOXD3-AS1, HOXC13-AS and positive control HOTTIP enrichment in WDR5 F266A RIP is calculated compared to their respective enrichments in WDR5-WT. GAPDH was used as negative control. Right panel: Expression of FLAG tagged WDR5 WT and WDR5 F266A mutant in HeLa cells by western blot. Data are shown as mean ± SD. ** P ≤ 0.01.

Journal: Nucleic Acids Research

Article Title: H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units

doi: 10.1093/nar/gky635

Figure Lengend Snippet: XH lncRNAs are overrepresented in active lncCARs. ( A ) Scatter plot showing enrichment of WDR5 lncRNAs over nuclear input. The X-axis denotes log transformed expression and Y-axis denotes log-fold change of WDR5 lncRNAs over nuclear input. Venn diagram, in the Scatter plot, shows 209 lncRNAs that are commonly enriched in both H3K4me2 and WDR5 ChRIP pulldowns. ( B ) Distribution of different patterns of genomic arrangements as described in Figure for WDR5 lncRNAs and non-CAR lncRNAs. ( C ) Distribution of different patterns of genomic arrangements as described in Figure for active lncRNA (ChRIP pulldown using H3K4me2 and WDR5 antibodies) and inactive lncRNA (ChRIP pulldown using EZH2 and H3K27me3 antibodies). ( D ) Nuclear expression levels of WDR5 XH lncRNAs, active XH lncCAR (WDR5 and H3K4me2) and non-CAR XH lncRNAs. ( E ) Enrichment of H3K4me2, H3K4me3, WDR5 ChIP-seq signals over active XH lncCAR (in green, n = 98) and non-CAR XH lncRNA (in black, n = 335) promoters (±2 kb) in BT-549 cells. The signals presented in the plots represent log 2 ratio between ChIP and input sample. TSS denotes the transcription start site of lncRNAs. ( F ) RT-qPCR analysis of WDR5 UV-RIP. The Y-axis shows fold enrichment relative to IgG. The significance of FOXD3-AS1 and HOXC13-AS enrichment in WDR5 RIP is calculated compared to the enrichment of FOXD3 and HOXC13 mRNAs, respectively. *** P ≤ 0.001. ( G ) Left panel: f-RIP of WDR5 WT and WDR5 F266A using FLAG antibody. The Y-axis shows percentage of Input. The significance of decrease in FOXD3-AS1, HOXC13-AS and positive control HOTTIP enrichment in WDR5 F266A RIP is calculated compared to their respective enrichments in WDR5-WT. GAPDH was used as negative control. Right panel: Expression of FLAG tagged WDR5 WT and WDR5 F266A mutant in HeLa cells by western blot. Data are shown as mean ± SD. ** P ≤ 0.01.

Article Snippet: BT-549 (CLS-300312; CLS cell line service, Germany), MDA-MB-231 (ACC-732; American Type Culture Collection, USA) and Hela (ATCC CCL-2) cell lines were cultured in DMEM (Invitrogen) supplemented with 10% FBS (Invitrogen) and 1% antibiotic cocktail (Pen-Strep, Invitrogen) at 37°C with 5% CO 2 supply.

Techniques: Transformation Assay, Expressing, ChIP-sequencing, Quantitative RT-PCR, Positive Control, Negative Control, Mutagenesis, Western Blot

Active XH lncCARs promote transcription of their protein coding partners. ( A and B ) Promoter targeting of active XH lncCARs detected by ChOP. A) qPCR analysis of ChOP pull-downs, performed using FOXD3-AS1 and HOXC13-AS antisense probes, with primers over TSS (transcription start sites), regions spanning upstream and downstream of TSS and over transcription termination sites (TTS) of FOXD3 and HOXC13 genes in BT-549 cells. The ChOP pull-down with LacZ antisense oligo, used as a negative control (grey bars). Specific enrichment pattern for each of the XH lncCARs is depicted in green bars. The schematic in the right of the bar graph represents the genomic locations of the respective primers (grey: not enriched and rosetta: showing enrichment). Data are shown as mean ± SD (n = 2 biological replicates). * P < 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( B ) Similar qPCR analysis of ChOP pull-downs using FOXD3-AS1 and HOXC13-AS antisense probes upon ActD treatment in BT-549 cells. Data are shown as mean ± SD ( n = 2 biological replicates). * P < 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( C ) RT-qPCR analysis to detect relative levels of nascent FOXD3 and HOXC13 transcripts by Click-iT at 48 hours after the knockdown of FOXD3-AS1 and HOXC13-AS . Bar graph depicts the level of nascent protein coding transcripts upon removal of their respective active XH lncCARs. Data represent the mean ± SD of two independent biological experiments. * if P ≤ 0.05 and ** if P ≤ 0.01. ( D and E ) ChIP-qPCR analysis of the enrichment of H3K4me2 and H3K4me3 at the promoter region of FOXD3 (D) and HOXC13 (E) upon down regulation of active XH lncCAR FOXD3-AS1 and HOXC13-AS respectively. Fold enrichment of H3K4me2 and H3K4me3 was normalized to histone H3 and IgG. After normalization the ChIP data was represented as relative enrichment compare to control siRNA.The locations of ChIP primers used are depicted in schematic in the bottm of each bar graph. Data are shown as mean ± SD (n = 3 biological replicates). ** P ≤ 0.01 and *** P ≤ 0.001. ( F and G ) ChIP-qPCR analysis of enrichment of WDR5 at the promoter region of FOXD3(F) and HOXC13 (G) upon downregulation of active XH lncCAR FOXD3-AS1 and HOXC13-AS respectively. Fold enrichment of WDR5 was normalized to histone H3 and IgG. After normalization the ChIP data was represented as relative enrichment compare to control siRNA. The ChIP primers used in the experiment are same as described in panel D–E. Data are shown as mean ± SD (n = 3 biological replicates). ** P ≤ 0.01 and *** P ≤ 0.001. ( H and I ) FOXD3-AS1 and HOXC13-AS overexpression: RT–qPCR analysis of FOXD3 expression, upon ectopic overexpression of FOXD3-AS1 (H) and HOXC13-AS transcript (I) respectively, at Day 2 and Day 5 post transfection in BT-549 cell line. pcDNA empty vector transfection used as a control. Data represent the mean ± SD. of two independent biological experiments. P -values has been denoted as * if P ≤ 0.05, ** if P ≤ 0.01. ns denotes non-significant. ( J ) Cell fractionation in BT-549 cells show distribution of the overexpressed FOXD3-AS1 and HOXC13-AS transcripts. Data represent the mean ± SD of two independent biological experiments. GAPDH serves as positive control for cytoplasmic fraction, U6 and KCNQ1OT1 serves as positive control for nuclear fraction.

Journal: Nucleic Acids Research

Article Title: H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units

doi: 10.1093/nar/gky635

Figure Lengend Snippet: Active XH lncCARs promote transcription of their protein coding partners. ( A and B ) Promoter targeting of active XH lncCARs detected by ChOP. A) qPCR analysis of ChOP pull-downs, performed using FOXD3-AS1 and HOXC13-AS antisense probes, with primers over TSS (transcription start sites), regions spanning upstream and downstream of TSS and over transcription termination sites (TTS) of FOXD3 and HOXC13 genes in BT-549 cells. The ChOP pull-down with LacZ antisense oligo, used as a negative control (grey bars). Specific enrichment pattern for each of the XH lncCARs is depicted in green bars. The schematic in the right of the bar graph represents the genomic locations of the respective primers (grey: not enriched and rosetta: showing enrichment). Data are shown as mean ± SD (n = 2 biological replicates). * P < 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( B ) Similar qPCR analysis of ChOP pull-downs using FOXD3-AS1 and HOXC13-AS antisense probes upon ActD treatment in BT-549 cells. Data are shown as mean ± SD ( n = 2 biological replicates). * P < 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. ( C ) RT-qPCR analysis to detect relative levels of nascent FOXD3 and HOXC13 transcripts by Click-iT at 48 hours after the knockdown of FOXD3-AS1 and HOXC13-AS . Bar graph depicts the level of nascent protein coding transcripts upon removal of their respective active XH lncCARs. Data represent the mean ± SD of two independent biological experiments. * if P ≤ 0.05 and ** if P ≤ 0.01. ( D and E ) ChIP-qPCR analysis of the enrichment of H3K4me2 and H3K4me3 at the promoter region of FOXD3 (D) and HOXC13 (E) upon down regulation of active XH lncCAR FOXD3-AS1 and HOXC13-AS respectively. Fold enrichment of H3K4me2 and H3K4me3 was normalized to histone H3 and IgG. After normalization the ChIP data was represented as relative enrichment compare to control siRNA.The locations of ChIP primers used are depicted in schematic in the bottm of each bar graph. Data are shown as mean ± SD (n = 3 biological replicates). ** P ≤ 0.01 and *** P ≤ 0.001. ( F and G ) ChIP-qPCR analysis of enrichment of WDR5 at the promoter region of FOXD3(F) and HOXC13 (G) upon downregulation of active XH lncCAR FOXD3-AS1 and HOXC13-AS respectively. Fold enrichment of WDR5 was normalized to histone H3 and IgG. After normalization the ChIP data was represented as relative enrichment compare to control siRNA. The ChIP primers used in the experiment are same as described in panel D–E. Data are shown as mean ± SD (n = 3 biological replicates). ** P ≤ 0.01 and *** P ≤ 0.001. ( H and I ) FOXD3-AS1 and HOXC13-AS overexpression: RT–qPCR analysis of FOXD3 expression, upon ectopic overexpression of FOXD3-AS1 (H) and HOXC13-AS transcript (I) respectively, at Day 2 and Day 5 post transfection in BT-549 cell line. pcDNA empty vector transfection used as a control. Data represent the mean ± SD. of two independent biological experiments. P -values has been denoted as * if P ≤ 0.05, ** if P ≤ 0.01. ns denotes non-significant. ( J ) Cell fractionation in BT-549 cells show distribution of the overexpressed FOXD3-AS1 and HOXC13-AS transcripts. Data represent the mean ± SD of two independent biological experiments. GAPDH serves as positive control for cytoplasmic fraction, U6 and KCNQ1OT1 serves as positive control for nuclear fraction.

Article Snippet: BT-549 (CLS-300312; CLS cell line service, Germany), MDA-MB-231 (ACC-732; American Type Culture Collection, USA) and Hela (ATCC CCL-2) cell lines were cultured in DMEM (Invitrogen) supplemented with 10% FBS (Invitrogen) and 1% antibiotic cocktail (Pen-Strep, Invitrogen) at 37°C with 5% CO 2 supply.

Techniques: Negative Control, Quantitative RT-PCR, Knockdown, IF-P, ChIP-qPCR, Control, Over Expression, Expressing, Transfection, Plasmid Preparation, Cell Fractionation, Positive Control

Differential expression and prognostic analysis of APOBEC3B. A. The mRNA expression of APOBEC3B in different tumour tissues and adjacent normal tissues based on the TCGA database. B. APOBEC3B expression in 52 pairs of PCa tissues and adjacent normal tissues in the TCGA database. C. APOBEC3B expression with Gleason Score in PCa patients based on TCGA database. D. PCa patients’ DFS for individuals in the TCGA database was assessed in terms of quartile via the Kaplan-Meier method (Log-rank test) using GEPIA2. E. APOBEC3B expression in docetaxel-resistant PCa cells (DU145/DR and PC-3/DR) and corresponding parental sensitive cells (DU145 and PC-3) measured by qRT-PCR and Western blot. U6 was used as a normalization reference at the mRNA level, and GAPDH was used as a loading control at the protein level. *, P <0.05; **, P <0.01; ***, P <0.001; ****, P <0.0001.

Journal: Translational Oncology

Article Title: MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

doi: 10.1016/j.tranon.2023.101723

Figure Lengend Snippet: Differential expression and prognostic analysis of APOBEC3B. A. The mRNA expression of APOBEC3B in different tumour tissues and adjacent normal tissues based on the TCGA database. B. APOBEC3B expression in 52 pairs of PCa tissues and adjacent normal tissues in the TCGA database. C. APOBEC3B expression with Gleason Score in PCa patients based on TCGA database. D. PCa patients’ DFS for individuals in the TCGA database was assessed in terms of quartile via the Kaplan-Meier method (Log-rank test) using GEPIA2. E. APOBEC3B expression in docetaxel-resistant PCa cells (DU145/DR and PC-3/DR) and corresponding parental sensitive cells (DU145 and PC-3) measured by qRT-PCR and Western blot. U6 was used as a normalization reference at the mRNA level, and GAPDH was used as a loading control at the protein level. *, P <0.05; **, P <0.01; ***, P <0.001; ****, P <0.0001.

Article Snippet: Through a series of steps, chemoresistance to docetaxel was developed in DU145 (DU145/DR) and PC-3 (PC-3/DR) cells and then maintained by growing in complete media containing 10 nM docetaxel (MCE, USA) .

Techniques: Quantitative Proteomics, Expressing, Quantitative RT-PCR, Western Blot, Control

Silencing of APOBEC3B inhibited PCa cell proliferation and chemoresistance. A. The APOBEC3B expression in docetaxel-resistant cells DU145/DR and PC-3/DR transfected with siNC or siAPOBEC3B for 48 h was determined by qRT-PCR and Western blot. Expression of APOBEC3B at the mRNA level was normalized by U6. GAPDH was used as a loading control at the protein level. B. Cell viability of DU145/DR and PC-3/DR cells transfected with siNC or siAPOBEC3B determined by CCK-8 assay. C. Colony formation assay of DU145/DR and PC-3/DR cells transfected with siNC or siAPOBEC3B. D. Chemosensitivity analysis of DU145/DR and PC-3/DR cells to docetaxel after APOBEC3B knockdown. Docetaxel-resistant cells (DU145/DR and PC-3/DR) transfected with siRNA for 24 h in 6-well plates were digested and then seeded into 96-well plates, respectively. Adherent cells were treated with docetaxel diluted in a gradient for another 48 h before performing CCK-8 analysis. Then, calculate the IC50 of siAPOBEC group and siNC group. The IC50s of DU145/DR: siNC, 62.17; siAPOBEC3B#2, 32.87; siAPOBEC3B#3, 28.60; The IC50s of PC-3/DR: siNC, 37.14; siAPOBEC3B#2, 18.50; siAPOBEC3B#3: 17.43. *, P<0.05; **, P<0.01; ***, P<0.001, ****, P<0.0001.

Journal: Translational Oncology

Article Title: MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

doi: 10.1016/j.tranon.2023.101723

Figure Lengend Snippet: Silencing of APOBEC3B inhibited PCa cell proliferation and chemoresistance. A. The APOBEC3B expression in docetaxel-resistant cells DU145/DR and PC-3/DR transfected with siNC or siAPOBEC3B for 48 h was determined by qRT-PCR and Western blot. Expression of APOBEC3B at the mRNA level was normalized by U6. GAPDH was used as a loading control at the protein level. B. Cell viability of DU145/DR and PC-3/DR cells transfected with siNC or siAPOBEC3B determined by CCK-8 assay. C. Colony formation assay of DU145/DR and PC-3/DR cells transfected with siNC or siAPOBEC3B. D. Chemosensitivity analysis of DU145/DR and PC-3/DR cells to docetaxel after APOBEC3B knockdown. Docetaxel-resistant cells (DU145/DR and PC-3/DR) transfected with siRNA for 24 h in 6-well plates were digested and then seeded into 96-well plates, respectively. Adherent cells were treated with docetaxel diluted in a gradient for another 48 h before performing CCK-8 analysis. Then, calculate the IC50 of siAPOBEC group and siNC group. The IC50s of DU145/DR: siNC, 62.17; siAPOBEC3B#2, 32.87; siAPOBEC3B#3, 28.60; The IC50s of PC-3/DR: siNC, 37.14; siAPOBEC3B#2, 18.50; siAPOBEC3B#3: 17.43. *, P<0.05; **, P<0.01; ***, P<0.001, ****, P<0.0001.

Article Snippet: Through a series of steps, chemoresistance to docetaxel was developed in DU145 (DU145/DR) and PC-3 (PC-3/DR) cells and then maintained by growing in complete media containing 10 nM docetaxel (MCE, USA) .

Techniques: Expressing, Transfection, Quantitative RT-PCR, Western Blot, Control, CCK-8 Assay, Colony Assay, Knockdown

miR-138–5p directly targeted APOBEC3B. A. The upstream target genes of APOBEC3B were predicted and screened by the database. B. The expression level of miR-138–5p in docetaxel-sensitive cells (DU145 and PC-3) and docetaxel-resistant cells (DU145/DR And PC-3/DR) was evaluated by qRT-PCR. C. The expression efficiency of miR-138–5p in docetaxel-resistant PCa cells transfected with mimics or inhibitors detected by qRT-PCR. d-E. Effect of miR-138–5p mimics and inhibitor on APOBEC3B expression in docetaxel-resistant PCa cells by qRT-PCR (D) and Western blot (E). U6 was used as the internal reference for miR-138–5p and APOBEC3B at the mRNA level. GAPDH was used as the loading control at the protein level. F. Schematic depiction of the interaction between miR-138–5p and APOBEC3B mRNA 3′-UTR. G. The wild-type and mutant-type plasmids of APOBEC3B mRNA 3′-UTR were constructed on the putative binding sites of miR-138–5p and APOBEC3B mRNA. H. Dual luciferase activity assay confirmed that miR-138–5p mimics negatively regulates APOBEC3B expression by binding to wild-type APOBEC3B mRNA 3′-UTR instead of mutant-type. I. Dual luciferase activity assay confirmed that miR-138–5p inhibitor upregulated APOBEC3B expression by binding wild-type APOBEC3B mRNA 3′-UTR instead of mutant-type. ns, no significance; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.

Journal: Translational Oncology

Article Title: MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

doi: 10.1016/j.tranon.2023.101723

Figure Lengend Snippet: miR-138–5p directly targeted APOBEC3B. A. The upstream target genes of APOBEC3B were predicted and screened by the database. B. The expression level of miR-138–5p in docetaxel-sensitive cells (DU145 and PC-3) and docetaxel-resistant cells (DU145/DR And PC-3/DR) was evaluated by qRT-PCR. C. The expression efficiency of miR-138–5p in docetaxel-resistant PCa cells transfected with mimics or inhibitors detected by qRT-PCR. d-E. Effect of miR-138–5p mimics and inhibitor on APOBEC3B expression in docetaxel-resistant PCa cells by qRT-PCR (D) and Western blot (E). U6 was used as the internal reference for miR-138–5p and APOBEC3B at the mRNA level. GAPDH was used as the loading control at the protein level. F. Schematic depiction of the interaction between miR-138–5p and APOBEC3B mRNA 3′-UTR. G. The wild-type and mutant-type plasmids of APOBEC3B mRNA 3′-UTR were constructed on the putative binding sites of miR-138–5p and APOBEC3B mRNA. H. Dual luciferase activity assay confirmed that miR-138–5p mimics negatively regulates APOBEC3B expression by binding to wild-type APOBEC3B mRNA 3′-UTR instead of mutant-type. I. Dual luciferase activity assay confirmed that miR-138–5p inhibitor upregulated APOBEC3B expression by binding wild-type APOBEC3B mRNA 3′-UTR instead of mutant-type. ns, no significance; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.

Article Snippet: Through a series of steps, chemoresistance to docetaxel was developed in DU145 (DU145/DR) and PC-3 (PC-3/DR) cells and then maintained by growing in complete media containing 10 nM docetaxel (MCE, USA) .

Techniques: Expressing, Quantitative RT-PCR, Transfection, Western Blot, Control, Mutagenesis, Construct, Binding Assay, Luciferase, Activity Assay

miR-138–5p inhibited cell proliferation and chemoresistance in docetaxel-resistant PCa cells. A-B. Effects of miR-138–5p mimics (A) or inhibitor (B) on the cell viability of docet-axel-resistant PCa cells. C. Effects of miR-138–5p mimics or inhibitor on the colony formation of docetaxel-resistant PCa cells. D. miR-138–5p mimics inhibited resistance against docetaxel of docetaxel-resistant PCa cells. E. miR-138–5p inhibitor promoted resistance against docetaxel of docetaxel-resistant PCa cells. Docetaxel-resistant cells (DU145/DR and PC-3/DR) transfected with mimics or inhibitor of miR-138–5p for 24 h in 6-well plates were seeded into 96-well plates, respectively, and then treated with docetaxel diluted in a gradient for another 48 h before performing CCK-8 analysis. The IC50s were calculated based on CCK-8 data. The IC50s of DU145/DR: mimic NC, 61.48; miR-138–5p mimics, 28.33; inhibitor NC, 60.34; miR-138–5p inhibitor: 122.80. The IC50s of PC-3/DR: mimic NC, 38.25; miR-138–5p mimics, 17.52; inhibitor NC, 37.66; miR-138–5p inhibitor: 83.74. *, P <0.05; **, P <0.01; ***, P <0.001, ****, P <0.0001.

Journal: Translational Oncology

Article Title: MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

doi: 10.1016/j.tranon.2023.101723

Figure Lengend Snippet: miR-138–5p inhibited cell proliferation and chemoresistance in docetaxel-resistant PCa cells. A-B. Effects of miR-138–5p mimics (A) or inhibitor (B) on the cell viability of docet-axel-resistant PCa cells. C. Effects of miR-138–5p mimics or inhibitor on the colony formation of docetaxel-resistant PCa cells. D. miR-138–5p mimics inhibited resistance against docetaxel of docetaxel-resistant PCa cells. E. miR-138–5p inhibitor promoted resistance against docetaxel of docetaxel-resistant PCa cells. Docetaxel-resistant cells (DU145/DR and PC-3/DR) transfected with mimics or inhibitor of miR-138–5p for 24 h in 6-well plates were seeded into 96-well plates, respectively, and then treated with docetaxel diluted in a gradient for another 48 h before performing CCK-8 analysis. The IC50s were calculated based on CCK-8 data. The IC50s of DU145/DR: mimic NC, 61.48; miR-138–5p mimics, 28.33; inhibitor NC, 60.34; miR-138–5p inhibitor: 122.80. The IC50s of PC-3/DR: mimic NC, 38.25; miR-138–5p mimics, 17.52; inhibitor NC, 37.66; miR-138–5p inhibitor: 83.74. *, P <0.05; **, P <0.01; ***, P <0.001, ****, P <0.0001.

Article Snippet: Through a series of steps, chemoresistance to docetaxel was developed in DU145 (DU145/DR) and PC-3 (PC-3/DR) cells and then maintained by growing in complete media containing 10 nM docetaxel (MCE, USA) .

Techniques: Transfection, CCK-8 Assay

APOBEC3B overexpression blocked the function of miR-138–5p on cell proliferation and docetaxel resistance. A. The overexpression efficiency of miR-138–5p in docetaxel-resistant PCa cells transfected with mimics detected by qRT-PCR. B. APOBEC3B overexpression level of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid determined by Western blot. C. Cell viability of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid determined by CCK-8 assay. D. Colony formation assay of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid. E. The chemosensitivity of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid to docetaxel was determined by CCK-8 assay. After docetaxel-resistant PCa cells were transfected with mimic NC plus OE-NC (control vector), miR-138–5p mimics plus OE-NC, mimic NC plus APOBEC3B-OE, or miR-138–5p mimics plus APOBEC3B-OE (mimic NC plus OE-NC vs miR-138–5p mimics plus OE-NC, and miR-138–5p mimics plus OE-NC vs miR-138–5p mimics plus APOBEC3B-OE-NC, respectively), CCK-8 viability assay was performed at 0, 24, 48, 72 and 96 h (B) and chemosensitivity was measured after incubation with docetaxel diluted in a gradient for another 48 h (E). The IC50s of DU145/DR: mimic NC + OE-NC, 63.77; miR-138–5p mimics + OE-NC, 31.20; miR-138–5p mimics + APOBEC3B-OE, 50.17. The IC50s of PC-3/DR: mimic NC + OE-NC, 38.43; miR-138–5p mimics + OE-NC, 18.74; miR-138–5p mimics + APOBEC3B-OE, 29.80. ns, no significance; *, P <0.05; **, P <0.01; ***, P <0.001; ****, P <0.0001, mimic NC plus OE-NC transfection group vs miR-138–5p mimics plus OE-NC transfection group. #, P <0.05; ###, P <0.001, miR-138–5p mimics plus OE-NC transfection group vs miR-138–5p mimics plus APOBEC3B-OE transfection group.

Journal: Translational Oncology

Article Title: MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

doi: 10.1016/j.tranon.2023.101723

Figure Lengend Snippet: APOBEC3B overexpression blocked the function of miR-138–5p on cell proliferation and docetaxel resistance. A. The overexpression efficiency of miR-138–5p in docetaxel-resistant PCa cells transfected with mimics detected by qRT-PCR. B. APOBEC3B overexpression level of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid determined by Western blot. C. Cell viability of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid determined by CCK-8 assay. D. Colony formation assay of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid. E. The chemosensitivity of docetaxel-resistant PCa cells transfected with miR-138–5p and APOBEC3B overexpression plasmid to docetaxel was determined by CCK-8 assay. After docetaxel-resistant PCa cells were transfected with mimic NC plus OE-NC (control vector), miR-138–5p mimics plus OE-NC, mimic NC plus APOBEC3B-OE, or miR-138–5p mimics plus APOBEC3B-OE (mimic NC plus OE-NC vs miR-138–5p mimics plus OE-NC, and miR-138–5p mimics plus OE-NC vs miR-138–5p mimics plus APOBEC3B-OE-NC, respectively), CCK-8 viability assay was performed at 0, 24, 48, 72 and 96 h (B) and chemosensitivity was measured after incubation with docetaxel diluted in a gradient for another 48 h (E). The IC50s of DU145/DR: mimic NC + OE-NC, 63.77; miR-138–5p mimics + OE-NC, 31.20; miR-138–5p mimics + APOBEC3B-OE, 50.17. The IC50s of PC-3/DR: mimic NC + OE-NC, 38.43; miR-138–5p mimics + OE-NC, 18.74; miR-138–5p mimics + APOBEC3B-OE, 29.80. ns, no significance; *, P <0.05; **, P <0.01; ***, P <0.001; ****, P <0.0001, mimic NC plus OE-NC transfection group vs miR-138–5p mimics plus OE-NC transfection group. #, P <0.05; ###, P <0.001, miR-138–5p mimics plus OE-NC transfection group vs miR-138–5p mimics plus APOBEC3B-OE transfection group.

Article Snippet: Through a series of steps, chemoresistance to docetaxel was developed in DU145 (DU145/DR) and PC-3 (PC-3/DR) cells and then maintained by growing in complete media containing 10 nM docetaxel (MCE, USA) .

Techniques: Over Expression, Transfection, Quantitative RT-PCR, Plasmid Preparation, Western Blot, CCK-8 Assay, Colony Assay, Control, Viability Assay, Incubation

Expression of ERG, ETS-1, ETS-2 and ETV-4 in PC3 cell nuclear extracts and PCa tissues. Western blot analysis showed that ERG, ETS-1, ETS-2 and ETV-4 were expressed in (A) PC3 cell nuclear extracts, as well as in protein lysates prepared from (B) the PCa tissue samples of five patients.

Journal: International Journal of Molecular Medicine

Article Title: ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer

doi: 10.3892/ijmm.2012.1097

Figure Lengend Snippet: Expression of ERG, ETS-1, ETS-2 and ETV-4 in PC3 cell nuclear extracts and PCa tissues. Western blot analysis showed that ERG, ETS-1, ETS-2 and ETV-4 were expressed in (A) PC3 cell nuclear extracts, as well as in protein lysates prepared from (B) the PCa tissue samples of five patients.

Article Snippet: To investigate whether ERG is associated with ETS-1, ETS-2 and ETV-4 in PC3 cell nuclear extracts (Santa Cruz Biotechnology, Inc.), IP was performed using a rabbit polyclonal anti-ERG antibody (Gentex).

Techniques: Expressing, Western Blot

ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in PC3 cell nuclear extracts. Immunoprecipitation (IP) using an anti-ERG antibody showed that ERG is specifically associated with (A) ETS-2 and ETV-4, but not with (B) ETS-1, in PC3 cell nuclear extracts.

Journal: International Journal of Molecular Medicine

Article Title: ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer

doi: 10.3892/ijmm.2012.1097

Figure Lengend Snippet: ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in PC3 cell nuclear extracts. Immunoprecipitation (IP) using an anti-ERG antibody showed that ERG is specifically associated with (A) ETS-2 and ETV-4, but not with (B) ETS-1, in PC3 cell nuclear extracts.

Article Snippet: To investigate whether ERG is associated with ETS-1, ETS-2 and ETV-4 in PC3 cell nuclear extracts (Santa Cruz Biotechnology, Inc.), IP was performed using a rabbit polyclonal anti-ERG antibody (Gentex).

Techniques: Immunoprecipitation